| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.9 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.9 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |